Marit Austgulen Wick
Directeur Financier/CFO chez Sarsia Venture Management AS
Profil
Marit Austgulen Wick currently works at Gulen & Masfjorden Utvikling AS, as Director, Sarsia Venture Management AS, as Chief Financial Officer from 2005, and Sarsia Seed Management AS, as Partner & Chief Financial Officer from 2016.
Ms. Wick also formerly worked at Rieber & Son AS, as Accounting Director, NORDA ASA, as Chief Financial Officer, Colon AS, as Chief Financial Officer, Novel Diagnostics AS, as Chief Executive & Financial Officer, ScreenCancer AS, as Chief Financial Officer, and BerGenBio ASA, as Chief Financial Officer.
Ms. Wick received her graduate degree from Norwegian School of Economics & Business Administration.
Postes actifs de Marit Austgulen Wick
| Sociétés | Poste | Début |
|---|---|---|
Sarsia Venture Management AS
 Sarsia Venture Management AS Investment ManagersFinance Sarsia Venture Management AS (SVM) is a venture capital advisory and management firm based in Bergen, Norway. They manage and advise the Sarsia Life Science Fund, established in 2005, which focuses on life science and biotechnology opportunities in the Nordic region. | Directeur Financier/CFO | 05/09/2005 |
| Gulen & Masfjorden Utvikling AS | Directeur/Membre du Conseil | - |
Sarsia Seed Management AS
 Sarsia Seed Management AS Investment ManagersFinance Sarsia Seed Management AS is a venture capital firm headquartered in Bergen, Norway. The company was founded in 2006. | Directeur Financier/CFO | 01/01/2016 |
Anciens postes connus de Marit Austgulen Wick
| Sociétés | Poste | Fin |
|---|---|---|
| Colon AS | Directeur Financier/CFO | - |
| BERGENBIO ASA | Directeur Financier/CFO | - |
Rieber & Son AS
 Rieber & Son AS Food: Major DiversifiedConsumer Non-Durables Rieber & Son AS produces exports and supplies food products to the food service market and other food manufacturers. Its brands include Toro, Vitana, Delecta, Denja, Vetslands Lefsa, Mr. Lee, and Vossafår. Its business units are divided into three segments which reflect the main markets in which it operates. The operating segments are Western Europe, Central Europe and Russia/Others. The Western Europe segment comprises Norway, Denmark, Sweden, Germany, Benelux, the United States of America and the United Kingdom. The Central Europe segment is composed of Czech Republic, Slovakia and Poland. The Russia/Other segment produce and sell nuts in the market. The company was founded by Paul Gottlieb Rieber in 1839 and is headquartered in Bergen, Norway. | Comptroller/Controller/Auditor | - |
| NORDA ASA | Directeur Financier/CFO | - |
Novel Diagnostics AS
 Novel Diagnostics AS BiotechnologyHealth Technology Novel Diagnostics AS provides biomedical research and diagnostics development services. It sells and develops medical and diagnostic products and drives commercialization of research results. The firm also invests in securities; either in form of follow-up investments in companies already has invested in, or as part of other strategic investments. The company was founded on June 10, 2002 and is headquartered in Bergen, Norway. | Directeur Général | - |
Formation de Marit Austgulen Wick
| Norwegian School of Economics & Business Administration | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NORDA ASA | Commercial Services |
| BERGENBIO ASA | Health Technology |
| Entreprise privées | 7 |
|---|---|
Rieber & Son AS
Rieber & Son AS Food: Major DiversifiedConsumer Non-Durables Rieber & Son AS produces exports and supplies food products to the food service market and other food manufacturers. Its brands include Toro, Vitana, Delecta, Denja, Vetslands Lefsa, Mr. Lee, and Vossafår. Its business units are divided into three segments which reflect the main markets in which it operates. The operating segments are Western Europe, Central Europe and Russia/Others. The Western Europe segment comprises Norway, Denmark, Sweden, Germany, Benelux, the United States of America and the United Kingdom. The Central Europe segment is composed of Czech Republic, Slovakia and Poland. The Russia/Other segment produce and sell nuts in the market. The company was founded by Paul Gottlieb Rieber in 1839 and is headquartered in Bergen, Norway. | Consumer Non-Durables |
| Colon AS | |
Novel Diagnostics AS
Novel Diagnostics AS BiotechnologyHealth Technology Novel Diagnostics AS provides biomedical research and diagnostics development services. It sells and develops medical and diagnostic products and drives commercialization of research results. The firm also invests in securities; either in form of follow-up investments in companies already has invested in, or as part of other strategic investments. The company was founded on June 10, 2002 and is headquartered in Bergen, Norway. | Health Technology |
Sarsia Venture Management AS
Sarsia Venture Management AS Investment ManagersFinance Sarsia Venture Management AS (SVM) is a venture capital advisory and management firm based in Bergen, Norway. They manage and advise the Sarsia Life Science Fund, established in 2005, which focuses on life science and biotechnology opportunities in the Nordic region. | Finance |
Sarsia Seed Management AS
Sarsia Seed Management AS Investment ManagersFinance Sarsia Seed Management AS is a venture capital firm headquartered in Bergen, Norway. The company was founded in 2006. | Finance |
ScreenCancer AS
 ScreenCancer AS Medical/Nursing ServicesHealth Services ScreenCancer AS offers cancer screening and diagnostic program to the public. It provides a panel of screening tests for several major cancers such as colorectal, bladder, breast, prostate, skin, and lung. The company was founded by Christian Horn and Dagfinn Steinar Ogreid in 2007 and is headquartered in Sola, Norway. | Health Services |
| Gulen & Masfjorden Utvikling AS |
